|
Videla-Ristol A, Martinez-Vacas A, Garcia-Bernal D, Vidal-Sanz M, Villegas-Perez MP, Garcia-Ayuso D, Di Pierdomenico J. Minocycline and bone marrow-derived mononuclear cells as potential therapeutics for hereditary retinal degenerations. Acta Ophthalmol. 2026 Mar 10. doi: 10.1111/aos.70108. Online ahead of print. PubMed PMID: 41808280.
AÑO: 2026; IF: 2.8
|
41808280
|
Norte-Munoz M, Portela-Lomba M, Sobrado-Calvo P, Simon D, Di Pierdomenico J, Gallego-Ortega A, Perez M, Cabrera-Maqueda JM, Sierra J, Vidal-Sanz M, Moreno-Flores MT, Agudo-Barriuso M. Differential response of injured and healthy retinas to syngeneic and allogeneic transplantation of a clonal cell line of immortalized olfactory ensheathing glia: a double-edged sword. Neural Regen Res. 2025 Aug 1;20(8):2395-2407. doi: 10.4103/NRR.NRR-D-23-01631. Epub 2024 May 13. PubMed PMID: 39359096; PubMed Central PMCID: PMC11759016.
AÑO: 2025; IF: 6.7
|
|
Rodriguez-Ramirez KT, Galindo-Romero C, Lucas-Ruiz F, Vidal-Sanz M, Agudo-Barriuso M. Neuroprotection of retinal ganglion cells by agonism of the beta but not the alpha oestrogen receptor in the axotomized retina of male and female mice. Acta Ophthalmol. 2025 Aug;103(5):571-579. doi: 10.1111/aos.17454. Epub 2025 Feb 7. PubMed PMID: 39916676.
AÑO: 2025; IF: 2.8
|
|
Sanchez-Migallon MDC, Di Pierdomenico J, Gallego-Ortega A, Garcia-Ayuso D, Vidal-Sanz M, Agudo-Barriuso M, Valiente-Soriano FJ. Minocycline Administration Does Not Have an Effect on Retinal Ganglion Cell Survival in a Murine Model of Ocular Hypertension. Aging Dis. 2024 Oct 1;15(5):2241-2254. doi: 10.14336/AD.2024.0224. PubMed PMID: 38502581; PubMed Central PMCID: PMC11346395.
AÑO: 2024; IF: 6.9
|
|
Norte-Munoz M, Garcia-Bernal D, Garcia-Ayuso D, Vidal-Sanz M, Agudo-Barriuso M. Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina. Neural Regen Res. 2024 Mar;19(3):542-547. doi: 10.4103/1673-5374.380876. PubMed PMID: 37721282; PubMed Central PMCID: PMC10581591.
AÑO: 2024; IF: 6.7
|